Physician profile
Sacha Balmir
NPI 1255438131
$752.92
in general payments reported to CMS, 2019-2025
8 companies · $20.85 in 2025
The $20.85 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2021: $129 · 2022: $225 · 2023: $129 · 2025: $20.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $152.68 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $129.45 | 2021 | |
| Travere Therapeutics, INC. | $128.72 | 2023 | |
| Novo Nordisk INC | $124.04 | 2019 | |
| Calliditas Therapeutics US INC. | $109.58 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $73.24 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.85 | 2025 | Lifevest |
| Cumberland Pharmaceuticals, INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sacha Balmir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.